Last reviewed 2026-04-20 · How we verify

ketoaminoacid

National Taiwan University Hospital · FDA-approved active Small molecule Quality 1/100

ketoaminoacid is a Small molecule drug developed by National Taiwan University Hospital. It is currently FDA-approved.

At a glance

Generic name	ketoaminoacid
Sponsor	National Taiwan University Hospital
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Keto-/Amino Acid Supplemented Low Protein Diet in Patients With Chronic Kidney Disease (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ketoaminoacid CI brief — competitive landscape report
ketoaminoacid updates RSS · CI watch RSS
National Taiwan University Hospital portfolio CI

Frequently asked questions about ketoaminoacid

What is ketoaminoacid?

ketoaminoacid is a Small molecule drug developed by National Taiwan University Hospital.

Who makes ketoaminoacid?

ketoaminoacid is developed and marketed by National Taiwan University Hospital (see full National Taiwan University Hospital pipeline at /company/national-taiwan-university-hospital).

What development phase is ketoaminoacid in?

ketoaminoacid is FDA-approved (marketed).

Manufacturer: National Taiwan University Hospital — full pipeline
Therapeutic area: All drugs in Other
Compare: ketoaminoacid vs similar drugs
Pricing: ketoaminoacid cost, discount & access